Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€2.67
24.12.23
€5.00
31.08.25
-16.32%
05.01.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.12.23 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.83
24.12.23
€3.00
31.08.25
-47.35%
07.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.12.23 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€43.80
24.12.23
€100.00
28.02.26
73.52%
25.01.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.12.23 80%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.20
24.12.23
-
24.12.24
1.36%
06.01.24

Could be worthwhile Investment >10% per year
melinda 
24.12.23 0%
sell
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€2.90
22.12.23
-
22.12.24
-17.24%
26.12.23

Could be worthwhile Investment >10% per year
daimler1 
22.12.23 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€2.09
22.12.23
-
22.12.24
9.11%
23.12.23

Could be worthwhile Investment >10% per year
thomasw 
22.12.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€529.00
18.12.23
€558.00
18.12.24
6.62%
06.01.24

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
18.12.23 50%
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€5.22
15.12.23
-
15.12.24
56.32%
31.01.24

Saftman 
15.12.23 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€526.00
14.12.23
€558.00
14.12.24
0.57%
18.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
14.12.23 50%
sell
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.84
14.12.23
-
14.12.24
23.78%
23.12.23

Could be worthwhile Investment >10% per year
quelbe60 
14.12.23 50%
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.30
11.12.23
-
11.12.24
-0.94%
26.12.23

Could be worthwhile Investment >10% per year
daimler1 
11.12.23 50%
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.30
10.12.23
€6.00
31.05.25
-8.68%
04.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
10.12.23 60%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€13.80
10.12.23
€40.00
10.12.24
-19.13%
26.03.24

Could be very worthwhile Investment >20% year
Rising EBIT margin expected
High Investments for future growth
Very valuable balance sheet
WatchMen 
10.12.23 50%
buy
Genfit S.A.

Start price
Target price
Perf. (%)
€3.32
10.12.23
€4.90
31.05.25
5.43%
17.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
10.12.23 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€32.80
10.12.23
€55.00
30.06.25
33.54%
24.12.23

Could be very worthwhile Investment >20% year
BiotechBee 
10.12.23 70%
buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€2.75
10.12.23
€3.50
31.03.26
-3.09%
24.12.23

Could be very worthwhile Investment >20% year
BiotechBee 
10.12.23 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.51
10.12.23
-
10.12.24
21.03%
23.12.23

Could be worthwhile Investment >10% per year
michaelkr 
10.12.23 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.04
10.12.23
-
10.12.24
70.52%
23.12.23

Could be worthwhile Investment >10% per year
michaelkr 
10.12.23 50%
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.17
09.12.23
-
09.12.24
-
11.12.23

Could be very worthwhile Investment >20% year
Lokrim 
09.12.23 20%
buy
Amneal Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€6.05
09.12.23
-
09.12.24
-
11.12.23

Could be very worthwhile Investment >20% year
Lokrim 
09.12.23 20%
buy
Bayer AG

Start price
Target price
Perf. (%)
€31.93
08.12.23
-
08.12.24
0.11%
08.12.23

Could be very worthwhile Investment >20% year
bundfuture 
08.12.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€32.00
07.12.23
€38.00
07.12.24
-15.23%
26.03.24

Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
Snowman 
07.12.23 50%
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.22
05.12.23
-
05.12.24
-16.37%
09.12.23

Could be worthwhile Investment >10% per year
Vassago1 
05.12.23 50%
buy
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€4.00
02.12.23
€5.00
31.10.25
-30.50%
10.12.23

Could be very worthwhile Investment >20% year
BiotechBee 
02.12.23 50%
buy
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€2.34
02.12.23
€4.00
31.12.25
12.82%
07.01.24

Could be very worthwhile Investment >20% year
BiotechBee 
02.12.23 60%